Estadístiques de Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer
Visites totals
| views | |
|---|---|
| Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer | 314 |
Visites totals per mes
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 12 |
| September 2024 | 18 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| sabbaghi-ccr-defe.pdf(legacy) | 284 |
| sabbaghi-ccr-defe.pdf | 2 |
Vistes principals per país
| views | |
|---|---|
| United States | 199 |
| Spain | 27 |
| Germany | 12 |
| Ireland | 12 |
| France | 9 |
| Sweden | 9 |
| China | 7 |
| Australia | 5 |
| Switzerland | 5 |
| Iran | 5 |
| Belgium | 4 |
| Canada | 3 |
| Czechia | 3 |
| Japan | 3 |
| Taiwan | 3 |
| Netherlands | 2 |
| European Union | 1 |
| United Kingdom | 1 |
| South Korea | 1 |
| Mongolia | 1 |
| Thailand | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Ashburn | 55 |
| Fairfield | 31 |
| San Ramon | 24 |
| Barcelona | 16 |
| Dublin | 12 |
| Cambridge | 8 |
| Silver Spring | 7 |
| Mountain View | 6 |
| Redwood City | 6 |
| Menlo Park | 5 |
| Rifferswil | 5 |
| Seattle | 5 |
| Shenzhen | 4 |
| San Diego | 3 |
| Taipei | 3 |
| Addison | 2 |
| Ann Arbor | 2 |
| Boardman | 2 |
| Rotterdam | 2 |
| Tokyo | 2 |
| Toronto | 2 |
| Augusta | 1 |
| Bilbao | 1 |
| Braunschweig | 1 |
| Béziers | 1 |
| Córdoba | 1 |
| Enskede | 1 |
| Jacksonville | 1 |
| Kyoto | 1 |
| Lancaster | 1 |
| Los Angeles | 1 |
| Madrid | 1 |
| Magdeburg | 1 |
| Matawan | 1 |
| Narathiwat | 1 |
| North Chicago | 1 |
| Olías Del Rey | 1 |
| Phoenix | 1 |
| Pinjarra | 1 |
| Rochester | 1 |
| Rostock | 1 |
| San Jose | 1 |
| Santander | 1 |
| Shanghai | 1 |
| Stockholm | 1 |
| Sükhbaatar | 1 |
| Tehran | 1 |
| Vilafranca De Panades | 1 |